- Home
- RLMD vs DTF Comparison
RLMD vs DTF Comparison
Compare RLMD & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- DTF
- Stock Information
- Founded
- RLMD 2004
- DTF 1991
- Country
- RLMD United States
- DTF United States
- Employees
- RLMD N/A
- DTF N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- DTF Investment Managers
- Sector
- RLMD Health Care
- DTF Finance
- Exchange
- RLMD Nasdaq
- DTF Nasdaq
- Market Cap
- RLMD 67.7M
- DTF 79.9M
- IPO Year
- RLMD N/A
- DTF N/A
- Fundamental
- Price
- RLMD $2.09
- DTF $11.39
- Analyst Decision
- RLMD Hold
- DTF
- Analyst Count
- RLMD 2
- DTF 0
- Target Price
- RLMD $1.00
- DTF N/A
- AVG Volume (30 Days)
- RLMD 335.3K
- DTF 21.1K
- Earning Date
- RLMD 11-07-2025
- DTF 01-01-0001
- Dividend Yield
- RLMD N/A
- DTF 3.64%
- EPS Growth
- RLMD N/A
- DTF N/A
- EPS
- RLMD N/A
- DTF 0.44
- Revenue
- RLMD N/A
- DTF N/A
- Revenue This Year
- RLMD N/A
- DTF N/A
- Revenue Next Year
- RLMD N/A
- DTF N/A
- P/E Ratio
- RLMD N/A
- DTF $24.34
- Revenue Growth
- RLMD N/A
- DTF N/A
- 52 Week Low
- RLMD $0.24
- DTF $10.29
- 52 Week High
- RLMD $3.98
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- RLMD 55.74
- DTF 50.02
- Support Level
- RLMD $1.98
- DTF $11.35
- Resistance Level
- RLMD $2.27
- DTF $11.46
- Average True Range (ATR)
- RLMD 0.21
- DTF 0.05
- MACD
- RLMD -0.04
- DTF -0.01
- Stochastic Oscillator
- RLMD 64.22
- DTF 39.08
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.